Your choices regarding cookies on this site

Webinar|September 25, 2024
Data and modeling find nearly half the applicants in this group with better-than-average mortality.
Register for the RecordingThe number of Americans with severe obesity (BMI ≥40) has more than doubled since 2000 and now exceeds 9% of the adult population. This group has traditionally been regarded as virtually uninsurable due to its significantly elevated mortality. However, by treating the millions of Americans with severe obesity as a monolithic cohort with uniform risk—and subsequently jet-declining life insurance applications with BMIs ≥40—carriers run a risk of their own: missing out on an insurable population larger than some U.S. states.
In this webinar, we’ll use new research from Milliman IntelliScript’s latest indepth study to show that severe obesity mortality risk is complex and multifaceted. We’ll demonstrate the use of Irix® Medical Data and Risk Score to spot key comorbidities, stratify risk within severe obesity, and identify nearly half the individuals in this group who have better-than-average mortality.
Join this webinar to understand the significant opportunity presented by applicants who have severe obesity but are otherwise healthy—and how you can use data-driven tools to identify these millions more Americans who are, in fact, eminently insurable.
Medical directors, underwriters, actuaries, and other clinical professionals who assess health risk will benefit from an improved understanding of the real impact of BMI and especially severe obesity on mortality risk.
Kimberly Sapre, DMSc, PA-C
Medical Consultant
Emily Simons
Actuarial Analyst
Sue Bartholf, FSA, MAAA
Director, Solutions Consulting
Milliman and our third-party website analytics and performance partners use cookies on our website that may collect and use personal information in order to constantly improve website performance and reliability and to provide accurate and relevant information. By clicking “Accept,” you consent to the placement and use of cookies by Milliman and our third-party partners for these purposes. You can learn more about how this site uses cookies and related technologies by reading our privacy policy